Wyeth, Impax Head To Court Over Effexor
Despite settling litigation over blockbuster drug Effexor in October, drug maker Wyeth is heading back to court to defend the popular antidepressant after another generic drug maker took a swipe at...To view the full article, register now.
Already a subscriber? Click here to view full article